<!-- S52 — Metas lipídicas: recomendação por categoria (v7) -->
<section class="slide" style="background: var(--bg); padding: var(--pad);">
  <p class="label-gold" style="margin-bottom: .35vw;">METAS LIP&Iacute;DICAS &mdash; TRADU&Ccedil;&Atilde;O EM RECOMENDA&Ccedil;&Atilde;O</p>
  <h2 style="margin: 0 0 .3vw 0;">Da categoria de risco &agrave; decis&atilde;o</h2>
  <p class="lead" style="margin: 0 0 0.6vw 0; max-width: 92%; font-size: 1.0vw;">
    Recomenda&ccedil;&otilde;es da Diretriz Brasileira de Dislipidemias (SBC 2025) para metas terap&ecirc;uticas conforme categoria de risco.
  </p>

  <div style="display:grid; grid-template-columns: 1fr 1fr 1.1fr; gap: 1.2vw; flex: 1;">
    <!-- Alto risco -->
    <div class="card" style="padding: 1.5vw; border: 1px solid rgba(15,23,42,.10); display: flex; flex-direction: column;">
      <div style="display:flex; align-items:center; justify-content:space-between; gap: .5vw; margin-bottom: 1.0vw;">
        <div>
          <div style="font-size: 0.92vw; font-weight: 900; text-transform: uppercase; letter-spacing: 0.1em; color: var(--muted);">ALTO RISCO</div>
          <div style="font-size: 0.82vw; color: var(--muted); margin-top:.1vw;">ex.: CAC &gt;100 ou &gt;p75</div>
        </div>
        <div style="display:flex; gap: .3vw; flex-wrap:wrap; justify-content:flex-end;">
          <span class="chip chip--gold" style="font-size: 0.55vw;">FORTE</span>
          <span class="chip chip--muted" style="font-size: 0.55vw;">ALTA</span>
        </div>
      </div>

      <div style="display:flex; align-items:baseline; gap:.6vw; margin-bottom: .7vw;">
        <div style="font-family: var(--font-serif); font-size: 4.2vw; font-weight: 800; color: var(--navy); line-height: 1;">&lt;70</div>
        <div style="font-size: 1.35vw; color: var(--muted);">mg/dL</div>
      </div>

      <div style="margin-bottom: 1.0vw; font-size: 1.15vw; color: var(--muted);">
        n&atilde;o&#8209;HDL&#8209;C <b style="color: var(--navy)">&lt;100</b> mg/dL
      </div>

      <ul style="margin: 0; padding-left: 1.2em; font-size: 1.18vw; line-height: 1.5;">
        <li style="margin-bottom: 0.55vw;">Estatina de alta pot&ecirc;ncia na dose m&aacute;xima tolerada.</li>
        <li style="margin-bottom: 0.55vw;">Se acima da meta: associar <b>ezetimiba</b>.</li>
        <li>Se persist&ecirc;ncia acima da meta: considerar terapia adicional conforme acesso.</li>
      </ul>
    </div>

    <!-- Muito alto risco -->
    <div class="card" style="padding: 1.5vw; border: 1px solid rgba(15,23,42,.10); display: flex; flex-direction: column;">
      <div style="display:flex; align-items:center; justify-content:space-between; gap: .5vw; margin-bottom: 1.0vw;">
        <div>
          <div style="font-size: 0.92vw; font-weight: 900; text-transform: uppercase; letter-spacing: 0.1em; color: var(--muted);">MUITO ALTO RISCO</div>
          <div style="font-size: 0.82vw; color: var(--muted); margin-top:.1vw;">ex.: CAC &gt;300</div>
        </div>
        <div style="display:flex; gap: .3vw; flex-wrap:wrap; justify-content:flex-end;">
          <span class="chip chip--gold" style="font-size: 0.55vw;">FORTE</span>
          <span class="chip chip--muted" style="font-size: 0.55vw;">ALTA</span>
        </div>
      </div>

      <div style="display:flex; align-items:baseline; gap:.6vw; margin-bottom: .7vw;">
        <div style="font-family: var(--font-serif); font-size: 4.2vw; font-weight: 800; color: var(--navy); line-height: 1;">&lt;50</div>
        <div style="font-size: 1.35vw; color: var(--muted);">mg/dL</div>
      </div>

      <div style="margin-bottom: 1.0vw; font-size: 1.15vw; color: var(--muted);">
        n&atilde;o&#8209;HDL&#8209;C <b style="color: var(--navy)">&lt;80</b> mg/dL
      </div>

      <ul style="margin: 0; padding-left: 1.2em; font-size: 1.18vw; line-height: 1.5;">
        <li style="margin-bottom: 0.55vw;">Estatina de alta pot&ecirc;ncia na dose m&aacute;xima tolerada + <b>ezetimiba</b>.</li>
        <li style="margin-bottom: 0.55vw;">Se persist&ecirc;ncia acima da meta: adicionar <b>inibidor de PCSK9</b> ou <b>&aacute;cido bemped&oacute;ico</b>.</li>
        <li>Intensifica&ccedil;&atilde;o precoce pelo maior benef&iacute;cio absoluto.</li>
      </ul>
    </div>

    <!-- Risco extremo — FOCAL -->
    <div class="card" style="padding: 1.5vw; border: 2px solid rgba(var(--gold-rgb), 0.35); background: rgba(var(--gold-rgb), 0.03); display: flex; flex-direction: column;">
      <div style="display:flex; align-items:center; justify-content:space-between; gap: .5vw; margin-bottom: 1.0vw;">
        <div>
          <div style="font-size: 0.92vw; font-weight: 900; text-transform: uppercase; letter-spacing: 0.1em; color: var(--gold-dark);">RISCO EXTREMO</div>
          <div style="font-size: 0.82vw; color: var(--muted); margin-top:.1vw;">categoria nova na SBC 2025</div>
        </div>
        <div style="display:flex; gap: .3vw; flex-wrap:wrap; justify-content:flex-end;">
          <span class="chip chip--gold" style="font-size: 0.55vw;">FORTE</span>
          <span class="chip chip--muted" style="font-size: 0.55vw;">MODERADA</span>
        </div>
      </div>

      <div style="display:flex; align-items:baseline; gap:.6vw; margin-bottom: .7vw;">
        <div style="font-family: var(--font-serif); font-size: 4.5vw; font-weight: 800; color: var(--gold-dark); line-height: 1;">&lt;40</div>
        <div style="font-size: 1.35vw; color: var(--gold-dark);">mg/dL</div>
      </div>

      <div style="margin-bottom: 1.0vw; font-size: 1.15vw; color: var(--muted);">
        n&atilde;o&#8209;HDL&#8209;C <b style="color: var(--gold-dark)">&lt;70</b> mg/dL
      </div>

      <ul style="margin: 0; padding-left: 1.2em; font-size: 1.18vw; line-height: 1.5;">
        <li style="margin-bottom: 0.55vw;">Estatina de alta pot&ecirc;ncia + <b>ezetimiba</b> + terapia adicional quando necess&aacute;rio.</li>
        <li style="margin-bottom: 0.55vw;">Considerar <b>inibidor de PCSK9</b> precocemente.</li>
        <li>Decis&atilde;o compartilhada: avaliar acesso, custo, prefer&ecirc;ncias do paciente.</li>
      </ul>

      <!-- Ganho marginal — evidência Tier 1 -->
      <div style="margin-top: auto; padding: 0.6vw 0.7vw; background: rgba(var(--gold-rgb), 0.06); border: 1px solid rgba(var(--gold-rgb), 0.18); border-radius: 0.35vw;">
        <div style="font-size: 0.95vw; line-height: 1.45; color: var(--navy);">
          <b>Ganho marginal linear:</b> redu&ccedil;&atilde;o de eventos CV proporcional &agrave; queda de LDL&#8209;C, sem plateau at&eacute; &lt;10 mg/dL (FOURIER; p&#8209;intera&ccedil;&atilde;o&nbsp;=&nbsp;0,78).
        </div>
        <div style="font-size: 0.72vw; color: var(--muted); margin-top: 0.15vw;">
          D'Andrea et al. EHJ-CVP 2023 (10 RCTs, n=109.095); Marston et al. Circulation 2021; Sabatine et al. NEJM 2017.
        </div>
      </div>
    </div>
  </div>

  <div class="ref" style="margin-top: auto; padding-top: 0.3vw;">
    Metas: SBC 2025 &mdash; Arq Bras Cardiol. 2025;122(9):e20250640. Ganho marginal: D'Andrea et al. EHJ-CVP 2023;9:138-147; Marston NA et al. Circulation 2021;144:1330-1332; Sabatine MS et al. NEJM 2017;376:1713-1722.
  </div>
</section>
